Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and ferrous gluconate.

Campbell, N; Paddock, V; Sundaram, R

Campbell, N; Paddock, V; Sundaram, R.

Affiliation

Campbell N; Department of Medicine, Memorial University of Newfoundland, St. John's, Canada.

Clin Pharmacol Ther ; 43(4): 381-6, 1988 Apr.

Article in En | MEDLINE | ID: mdl-3356082

Subject(s)

Blood Pressure/drug effects; Ferrous Compounds/pharmacology; Methyldopa/metabolism; Administration, Oral; Adult; Aged; Drug Interactions; Female; Humans; Hypertension/drug therapy; Intestinal Absorption/drug effects; Male; Methyldopa/pharmacokinetics; Methyldopa/therapeutic use; Random Allocation

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Pressure / Ferrous Compounds / Methyldopa Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 1988 Document type: Article Affiliation country: Canada

Search on Google

Add to My VHL

XML

PubMed Links